Financials
- Market Capitalization 8.06 M
- Employee N/A
- Founded 2021
- CEO N/A
- Website www.aspirebiolabs.com
- Headquarter Cayman Islands
- FIGI BBG015STV133
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.36
ratio cours/chiffre d'affaires
-3.19
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4851 | ERNA Ernexa Therapeutics Inc. - Common Stock | 7.15 USD | +17.99% | +15.14% | +18.57% | +1945.78% | 8.34 M USD | ||
| 4855 | IMNN Imunon, Inc. - Common Stock | 1.93 USD | -2.03% | -3.02% | -1.03% | -40.62% | 8.11 M USD | ||
| 4861 | BOLT Bolt Biotherapeutics, Inc. - Common Stock | 4.15 USD | +2.47% | +2.72% | -10.75% | -27.19% | 7.97 M USD | ||
| 4866 | AEON AEON Biopharma, Inc. Class A Common Stock | 0.30 USD | -14.29% | -58.33% | -55.22% | -71.15% | 7.89 M USD |